For extended storagespanning several months or longerfreezing is advised
For example, administration of 2.4 mg/week of semaglutide (instead of 1 mg used in diabetics) for 68 weeks leads to average losses of 15% of initial body weight, approximately double that in type 2 diabetics (Figure 5A)
Consider this scenario: a patient who loses their target weight in 12 months on tirzepatide at $350 per month (compounded) versus 18 months on semaglutide at $250 per month (compounded) ends up spending roughly $4,200 versus $4,500 total, despite tirzepatides higher monthly price
Limited Weight Loss from Staying on Low Doses The importance of proper dose titration cannot be overstated, yet many patients remain on low doses, limiting their weight loss results
Although every effort is made to provide accurate information, we cannot be held responsible for any inaccuracies or incorrect information that may be found on this site